Overview

The Division of Skin and Rheumatic Diseases promotes and supports basic, translational, and clinical studies of skin, wound healing, and skin disorders, as well as adult and pediatric rheumatic diseases. Approaches supported may include, but are not limited to, molecular and cell biology research; animal model construction; genetics and genomics research; identification of risk factors, autoimmunity, and inflammation research; biopsychosocial/behavioral research; outcomes and health services research; and research leading to prevention, diagnosis, control and cure of these disorders.

Click here for a formatted brochure on the DSRD [PDF 3.5MB]

Research areas supported through the Division of Skin and Rheumatic Diseases include:

Division Director

Susana A. Serrate-Sztein, M.D.

One Democracy Boulevard
Building: Democracy 1, Room: 890
Bethesda MD 20892-4872

Funding Opportunities

Administrative Supplements for Research on Dietary Supplements (Admin Supp)

PA-17-307 | Release: | Exp:

This Funding Opportunity Announcement (FOA) announces the availability of administrative supplements to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. Parent awards need not be focused on dietary supplements; this FOA may provide support to include dietary supplements within the scope of relevant research projects. Research interests of ODS are not limited to specific health conditions, organ systems or population groups. ODS supports all types of research, including pre-clinical, clinical, behavioral, and epidemiological. Additionally, ODS supports research and training programs that build future research capacity for studying the role of dietary supplements in health and disease prevention. Primary consideration for support will be given to applications that stimulate dietary supplement research where it is lacking or lagging, clarify gaps, opportunities and balance between benefits and risks where data are in conflict, target special population groups where additional science on dietary supplements is needed, and focus on the use of dietary supplements in improving or maintaining health and reducing the risk of chronic disease. This FOA will not support new clinical trials.

PHS 2017-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])

PA-17-303 | Release: | Exp:

This Funding Opportunity Announcement (FOA) issued by the National Institutes of Health (NIH) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH awarding components identified in this FOA are encouraged to submit STTR grant applications in response to identified topics (see PHS 2017-2 SBIR/STTR Program Descriptions and Research Topics for NIH.

PHS 2017-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])

PA-17-302 | Release: | Exp:

This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. United States SBCs that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2017-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA.

Last Reviewed: 03/05/2017